title: Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
authors: Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
authors: K
authors: K
authors: Suzuki
authors: K
authors: K
authors: Tanabe
authors: T
authors: T
authors: Tokumoto
authors: T
authors: T
authors: Shimizu
authors: N
authors: N
authors: Ishikawa
authors: T
authors: T
authors: Yagisawa
authors: K
authors: K
authors: Honda
authors: H
authors: H
authors: Nihei
authors: H
authors: H
authors: Toma
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000601:surgery*; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D012263:Ribonucleosides / Q000627:therapeutic use; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone